TP53 and cancer: Mutations of p53, such as that which appeared in PLC/PRF/5 human hepatocellular carcinoma cells, result in the loss of p53 functions, leading to abnormalities in cell death and cell cycle arrest and allowing invasion and metastasis of cancer cells [6,38].